NATIONAL HEALTHCARE CORP 10-Q

Item 4. Controls and Procedures .   As of September 30, 2023, an evaluation was performed under the supervision and with the participation of the Company’s management, including the Chief Executive Officer (“CEO”) and Chief Financial Officer (“CFO”), of the effectiveness of the design and operation of the Company’s disclosure controls and procedures. Based on that evaluation, the Company’s management, including the CEO and CFO, concluded that the Company’s disclosure controls and procedures were effective as of September 30, 2023.   During the period covered by this report, there have been no changes in our internal control over financial reporting that have materially affected or are reasonably likely to materially affect our internal control over financial reporting.   38 Table of Contents   PART II. OTHER INFORMATION   Item 1. Legal Proceedings.   For a discussion of prior, current, and pending litigation of material significance to NHC, please see Note 17 of this Form 10–Q.   Item 1A. Risk Factors.   During the three months ended September 30, 2023, there were no material changes to the risk factors that were disclosed in Item 1A of National HealthCare Corporation’s Annual Report on Form 10-K for the year ended December 31, 2022.   Item 2. Unregistered Sales of Equity Securities and Use of Proceeds.   Not applicable   Item 3. Defaults Upon Senior Securities.   None   Item 4. Mine Safety Disclosures.   Not applicable